Raul Gainetdinov, Ph.D.

Italian Institute of Technology, Genoa, United States 
"Raul Gainetdinov"
Mean distance: 106866
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Illiano P, Leo D, Gainetdinov RR, et al. (2021) Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter. Biomedicines. 9
Sotnikova TD, Efimova EV, Gainetdinov RR. (2020) Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor. International Journal of Molecular Sciences. 21
Efimova EV, Kozlova AA, Razenkova V, et al. (2020) Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice. Neuropharmacology. 182: 108373
Sanna F, Bratzu J, Serra MP, et al. (2020) Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study. Frontiers in Behavioral Neuroscience. 14: 58
Espinoza S, Sukhanov I, Efimova EV, et al. (2020) Trace Amine-Associated Receptor 5 Provides Olfactory Input Into Limbic Brain Areas and Modulates Emotional Behaviors and Serotonin Transmission. Frontiers in Molecular Neuroscience. 13: 18
Adinolfi A, Zelli S, Leo D, et al. (2019) Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system. Behavioural Brain Research. 359: 516-527
Leo D, Sukhanov I, Gainetdinov RR. (2018) Novel translational rat models of dopamine transporter deficiency. Neural Regeneration Research. 13: 2091-2093
Lam VM, Mielnik CA, Baimel C, et al. (2018) Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953
Espinoza S, Leo D, Sotnikova TD, et al. (2018) Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397. Frontiers in Pharmacology. 9: 645
Schwartz MD, Canales JJ, Zucchi R, et al. (2018) Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion On Therapeutic Targets
See more...